_________ false

C002

טבע תעשיות פרמצבטיות בע"מ

2

Public

TEVA- PHARMACEUTICAL INDUSTRIES LTD.

7217

Corporation no: 520013954

Stock Exchange/Market: טבע

310

380

P.O.B 3190 , Petach Tikva 49131 , ,

Tel: 03-9267554 , 03-9267652 Fax: 03-9267519

E.mail address: elana.holzman@teva.co.il

Date of transmission: 02/11/2010

              Time of broadcast: 08:07 08:06:54

Reference: 2010-02-666441

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate Report

Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on TEVA REPORTS RECORD THIRD QUARTER 2010 RESULTS

q3final_isa.pdf

Attached is a press release containing Teva's third quarter's earnings results, filed today in the U.S., and its non-binding translation into Hebrew.

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):

Previous names of reporting entity:

Date of revision of form structure: 17/10/2010

Name of the Signatory: : Desheh Eyal , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: .

Basel Telephone: 02-9411717 , Facsimile: 02-9411718 , E-mail: eyal@teva.co.il 2